LEADER 01299nam  2200373   450 
001 9910702440703321
005 20140626165813.0
035   $a(CKB)5470000002427763
035   $a(OCoLC)881831530
035   $a(EXLCZ)995470000002427763
100   $a20140626d2012      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aMyoclonus
210  1$aBethesda, Maryland :$cU.S. Department of Health and Human Services, Public Health Service, National Institutes of Health,$d2012.
215   $a1 online resource (8 pages)
225 1 $aNIH publication ;$vno. 12-4793
300   $aTitle from title screen (viewed June 18, 2014).
300   $a"Prepared by: Office of Communications and Public Liaison, National Institute of Neurological Disorders and Stroke"--Page [10].
300   $a"July 2012"--Page [10].
517   $aMyoclonus 
606   $aMyoclonus
615  0$aMyoclonus.
712 02$aNational Institutes of Health (U.S.),
712 02$aNational Institute of Neurological Disorders and Stroke (U.S.).$bOffice of Communications and Public Liaison,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910702440703321
996   $aMyoclonus$93139605
997   $aUNINA